Home > Insider Trading > Filing (0001209191-15-041824)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1169987	Htg Molecular Diagnostics Inc	HTGM	Laboratory Analytical Instruments (3826)	860912294

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1388325	A/S Novo	Tuborg Havnevej 19 Hellerup G7 2900		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-05-11	754,538	$0.00	754,538	No	4	C	Direct
Common Stock	Acquisiton	2015-05-11	110,755	$0.00	865,293	No	4	C	Direct
Common Stock	Acquisiton	2015-05-11	49,786	$0.00	915,079	No	4	X	Direct
Common Stock	Acquisiton	2015-05-11	365,106	$14.00	1,280,185	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	X	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	SERIES D PREFERRED STOCK	Disposition	2015-05-11	598,415	$0.00	598,415	$0.00
Common Stock	SERIES E PREFERRED STOCK	Disposition	2015-05-11	156,123	$0.00	156,123	$0.00
Common Stock	CONVERTIBLE PROMISSORY NOTES (RIGHT TO BUY)	Disposition	2015-05-11	110,755	$0.00	110,755	$0.00
Common Stock	SERIES E PREFERRED STOCK WARRANTS (RIGHT TO BUY)	Disposition	2015-05-11	49,786	$0.00	49,786	$0.00

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
	No	4	C	Direct
	No	4	C	Direct
	No	4	C	Direct
2022-01-14	No	4	X	Direct

Footnotes

The Series D and Series E Preferred Stock (collectively, the "Preferred Stock") had no expiration date. Upon the closing of the Issuer's initial public offering (the "IPO Closing"), the Preferred Stock automatically converted on a one-for-one basis for no additional consideration into common stock and additional shares were issued for accrued but unpaid dividends on the Preferred Stock.
Upon the IPO Closing, convertible promissory notes in the aggregate principal amount of $1,535,440 and accrued and unpaid interest due on such notes (collectively, the "Note Conversion Amount") automatically converted into common stock equal to the Note Conversion Amount divided by $14.00 (the "IPO Per Share Price").
Upon the IPO Closing, an aggregate principal warrant coverage amount of $697, 015 was exercised for shares of common stock at the IPO Share Price.
Represents a purchase from the underwriters in the Issuer's public offering.